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ABSTRACT
Staphylococcus lugdunensis is a member of the coagulase-negative staphylococci with the potential to
cause clinically signiﬁcant infections. The spectrum of infections was investigated in 39 isolates of S.
lugdunensis from 38 patients. Most (73%) infections were located below the waist, while those above the
waist were mainly (5 ⁄ 7) breast abscesses. Most isolates were susceptible to the antibiotics tested,
although 15.4% were b-lactamase-positive and could be identiﬁed by the disk-diffusion method for
penicillin G. There was very good concordance between the disk-diffusion method and the Etest method
for oxacillin resistance. Pulsed-ﬁeld gel electrophoresis (PFGE) showed that 56% of the isolates belonged
to one SmaI pulsotype, while phenotypic analysis by the Phene Plate system identiﬁed three main
phenotypic groups. Although the S. lugdunensis isolates analysed were obtained from different patients,
treated in different wards and hospitals during a 4-year period, there was a low degree of diversity, both
genotypically and phenotypically. For this reason, PFGE is not suitable for the analysis of an outbreak
situation, and the homogeneity observed may indicate that S. lugdunensis is a genetically conserved
species of coagulase-negative Staphylococcus.
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INTRODUCTION
Staphylococcus lugdunensis is a member of the
coagulase-negative staphylococci (CoNS). This
species, ﬁrst described in 1988 by Freney et al.
[1], resembles Staphylococcus aureus more closely
than it does other CoNS, since it often causes
aggressive and rapidly progressive infections.
There are case reports of serious infective endo-
carditis, with rapid destruction of heart valves,
despite adequate antibiotic therapy [2–4], and of
septic shock [5,6]. S. lugdunensis has been shown
to cause meningitis secondary to ventriculo-peri-
toneal shunt infections, often with more extensive
symptoms than those caused by other CoNS [7–9].
In addition, S. lugdunensis has been isolated from
infections such as osteomyelitis [4,10–12], pros-
thetic joint infections [12,13], septic arthritis [14],
skin and post-surgical wound infections [15,16],
breast abscesses [17–19] and peritonitis associated
with continuous ambulatory peritoneal dialysis
[20].
S. lugdunensis can be misidentiﬁed as S. aureus
in the routine microbiological laboratory, since
the DNase test can be weakly positive, the
agglutination test for clumping factor can be
positive, and the colony morphology often resem-
bles that of S. aureus. Schnitzler et al. [21] sugges-
ted a screening strategy for identifying
S. lugdunensis, based on the fact that S. lugdunensis
is the only pyrrolidonyl arylamidase-positive
coagulase-negative staphylococcal species that is
also ornithine decarboxylase-positive. A deﬁnit-
ive identiﬁcation can be achieved by using iden-
tiﬁcation systems available commercially, or by
sequencing the 16S rRNA gene.
Compared with other CoNS, S. lugdunensis is
generally more sensitive to antibiotics used
against staphylococci. Only c. 20% of isolates are
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b-lactamase-positive (http://www.srga.org); i.e.,
it is often possible to use penicillin for treatment
of infections caused by these organisms. Only one
case involving a mecA-positive strain has been
reported [22]. S. lugdunensis is usually susceptible
to gentamicin, rifampicin, vancomycin and eryth-
romycin [23], and < 10% of isolates are resistant to
clindamycin or fusidic acid (http://www.srga.
org). However, resistance can develop during
antibiotic treatment, as shown by Kragsbjerg et al.
[4].
The aim of the present retrospective review of
S. lugdunensis isolates, collected between 1999 and
2003, was to characterise the clinical infections
caused by S. lugdunensis, and to investigate the
phenotypic and genotypic diversity of the
S. lugdunensis isolates, as well as their antibiotic
susceptibility patterns.
MATERIALS AND METHODS
Bacterial isolates and clinical data
The database at the Department of Clinical Microbiology,
O¨rebro University Hospital, identiﬁed 47 isolates of S. lugd-
unensis, collected between January 1999 and October 2003.
These isolates were identiﬁed as S. lugdunensis by STAPH-
zyme (Rosco Diagnostica, Taastrup, Denmark) or ID32Staph
(bioMe´rieux, Marcy l’Etoile, France). Routine diagnostic tests
also included DNase and clumping factor. Most (33 of 47; 70%)
isolates had an indeterminate DNase reaction, one (2%) isolate
was positive, and 13 (28%) were negative. Seventeen (36%)
isolates were positive for clumping factor, 13 (28%) were
negative, seven (15%) were indeterminate, and ten (21%) had
not been tested. The isolates had been stored at ) 70C in
preservation medium comprising trypticase soy broth con-
taining yeast extract 0.3% w ⁄v (Difco Laboratories, Sparks,
MD, USA) and horse serum 30% v ⁄v (BBL, Becton Dickinson,
Sparks, MD, USA).
The 47 isolates were obtained from 38 different patients
(one patient with four isolates, six patients with two isolates,
and 31 patients with one isolate each). Data were obtained
regarding the referral department, age and gender of the
patient, surgical procedures, sampling site, sample location,
type of sample material, and whether S. lugdunensis was the
only pathogen isolated from the sample.
Susceptibility testing
All 47 isolates were ﬁrst re-cultured on blood agar medium
(Columbia II Agar 4.25% w ⁄v, deﬁbrinised horse blood 6%
v ⁄v; SVA, Uppsala, Sweden). MIC determinations were by
Etest (AB Biodisk, Solna, Sweden) on IsoSensitest Agar (Oxoid,
Basingstoke, UK) for penicillin G, and on IsoSensitest Agar
(Oxoid) supplemented with deﬁbrinised horse blood 5% v ⁄v
and NAD 2% w ⁄v for oxacillin. Disk-diffusion tests (Oxoid)
for penicillin G, cefoxitin (10 lg), gentamicin, fusidic acid,
rifampicin, vancomycin, clindamycin and ciproﬂoxacin were
performed on IsoSensitest Agar, while oxacillin (1 lg) was
tested on IsoSensitest Agar supplemented with deﬁbrinised
horse blood 5% v ⁄v and NAD 2% w ⁄v. Tests for b-lactamase
production were performed with nitroceﬁn disks (AB Biodisk).
Susceptibility test methods and breakpoints were according to
the recommendations of the Swedish Reference Group for
Antibiotics (SRGA; http://www.srga.org). Isolates with MIC
values ‡ 1 mg ⁄L for oxacillin, or a zone diameter £ 12 mm for
oxacillin or £ 21 mm for cefoxitin, were tested for the presence
of mecA by LightCycler PCR and SYBR Green I dye as
described previously [24], with primers 5¢-GCAATCGC-
TAAAGAACTAAG (forward) and 5¢-GGGACCAACATAAC-
CTAATA (reverse).
Phene plate
All isolates were analysed biochemically by the Phene Plate
system (PhPlate AB, Stockholm, Sweden), modiﬁed for typing
CoNS, according to the manufacturer’s instructions. This
system consists of 96-well microplates, each with four sets of
24 reagents. A set of 22 dehydrated reagents is selected in order
to obtain high discrimination between various species of CoNS.
The reagents include fructose, galactose, mannose,
D-xylose, L-arabinose, D-ribose, maltose, lactose, sucrose, treha-
lose, turanose, melezitose, mannitol, xylitol, D-arabinose, gly-
cerol, deoxyribose, b-meglucoside, arbutin, urea, ornithine and
arginine. Two wells contain negative controls. The isolates
were pre-cultured on blood agar medium. Bacterial suspension
was dispensed into the reagent wells and the plates were
incubated at 35C. The absorbance value for each reaction was
measured at 620 nm after 16, 40 and 64 h. The absorbance
values were transferred automatically to a computer, multi-
plied by 10, and stored as integer values. After the last
measurement, the mean value of the three readings was
calculated for each reaction. The biochemical proﬁle of an
isolate thus consisted of a set of 22 numbers, each ranging from
0 (acid reaction) to 20 (neutral reaction). The results of different
isolates were compared pairwise, and the similarities of the
pairs were computed as correlation coefﬁcients. These were
clustered using the UPGMAmethod to produce a dendrogram.
Isolates with identical or very similar biochemical proﬁles, i.e.,
with a correlation coefﬁcient ‡ 0.975, were regarded as belong-
ing to the same Phene Plate type [25], but ﬁnal determination
was made by visual examination. All data processing, inclu-
ding optical readings and calculations of correlation coefﬁ-
cients, as well as clustering and printing of dendrograms, was
performed with Phene Plate software (PhPlate AB).
Pulsed-ﬁeld gel electrophoresis
Chromosomal SmaI digests were prepared with a GenePath
Group 1 Reagent Kit (Bio-Rad Laboratories, Hercules, CA,
USA) according to the manufacturer’s instructions. Pulsed-
ﬁeld gel electrophoresis (PFGE) was performed using the
GenePath System (Bio-Rad) and an agarose 1% w ⁄v gel in
0.5 · TBE buffer (45 mM Tris-borate, 1 mM EDTA) equili-
brated at 14C, with a constant voltage of 6 V ⁄ cm and pulses
ramped from 5.3 s to 34.9 s for 20 h at an angle of 120.
Differences in band patterns were processed and analysed
using Molecular Analyst Fingerprinting software (v. 1.6; Bio-
Rad) with the Dice coefﬁcient, and UPGMA clustering with
1% band tolerance and 0.5% optimisation. All comparisons
were validated ﬁnally by visual examination and interpreted
as recommended by Tenover et al. [26].
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RESULTS
Clinical data
The 38 patients were aged 7–89 years (median
64 years). Twenty-six (68%) were female, and
there was only one child (aged < 18 years). All
multiple isolates from the same patient were
indistinguishable following phenotypic and geno-
typic analysis (see below), with the exception of
two isolates (collected at an interval of 1 month)
from a patient with a diabetic foot ulcer; these two
isolates had distinct phenotypic and genotypic
patterns, as well as different antibiotic suscept-
ibility proﬁles. Both of these isolates (isolate
numbers 03T534 and 03T650) were included in
the study, which therefore consisted of 39 isolates
obtained from 38 patients.
Six patients had S. lugdunensis bacteraemia; one
of these patients had two episodes of bacteraemia
with S. lugdunensis (two positive aerobic and
anaerobic cultures on both occasions), separated
by almost a year, with no obvious focus of
infection. A second patient with bacteraemia
had veriﬁed infective endocarditis, and a third
patient also yielded a positive culture from an
infected prosthetic joint device.
The number of isolates obtained from different
sites of the body for 33 patients with focal
infections is shown in Table 1 (ﬁve patients who
only had positive blood cultures were excluded).
Twelve patients had abscesses with S. lugdunensis:
breast abscess (n = 5), inguinal abscess (n = 2),
scrotal abscess (n = 1), abscess of the thigh after a
knee arthroscopy (n = 1), abscess in the knee
region without joint involvement (n = 1), abscess
in the lower extremity (n = 1), and abscess of the
foot (n = 1). S. lugdunensis was isolated from the
synovial ﬂuid of four patients: from the knee joint
of three patients (one of whom had a knee joint
prosthesis), and from the hip joint of one patient
with a joint prosthesis. S. lugdunensis was isolated
in pure culture from the urine (106 CFU ⁄mL) of a
female aged 55 years with uncomplicated cystitis.
Seven patients (18%) had infections related to
previous surgery (Table 1).
S. lugdunensis was the only pathogen isolated
from 28 (74%) of the above 38 specimens. Seven
of the ten specimens that yielded species in
addition to S. lugdunensis were from chronic
ulcers, mainly on the foot or leg. Specimens from
breast abscesses and joint infections all yielded
S. lugdunensis in pure culture.
Susceptibility testing
Oxacillin MICs determined by Etest for the S.
lugdunensis isolates were 0.125–1.5 mg ⁄L (median
0.38 mg ⁄L). Two isolates with MICs of 1 and
1.5 mg ⁄L, respectively, both lackedmecA, but were
b-lactamase-positive. The b-lactamase-negative
isolates had penicillin G MICs of 0.008–
0.064 mg ⁄L, i.e., almost a ten-fold difference com-
pared with oxacillin. There was good agreement
between the disk-diffusion results for penicillin G
and b-lactamase positivity ⁄negativity. All b-lacta-
mase-positive isolates (6 ⁄ 39; 15.4%) had a zone
diameter £ 22 mm, while those that were b-lacta-
mase-negative had zone diameters ‡ 38 mm. All
isolates had a zone diameter ‡ 23 mm for cefoxitin,
and a zone diameter ‡ 15 mm for oxacillin; i.e., they
were all susceptible to cefoxitin and oxacillin when
tested by this method.
One isolate was resistant to both fusidic acid
and clindamycin, and one isolate was resistant
only to clindamycin. No resistance or reduced
susceptibility to gentamicin, rifampicin or vanco-
mycin was found, and all isolates showed inter-
mediate susceptibility to ciproﬂoxacin according
to the breakpoints recommended in 2004 by the
SRGA (http://www.srga.org).
Genotypic and phenotypic characterisation
SmaI PFGE identiﬁed six pulsotypes with £ 3
bands difference, each containing 2–22 isolates
(Fig. 1). Three isolates were found that did not
cluster with any other isolate. The majority (22 ⁄ 39;
56%) of isolates belonged to pulsotype A.
Table 1. Staphylococcus lugdunensis isolates obtained from
various body sites of 33 patients with focal infections
Body site Number of patients Surgical procedure
Above waist
Breast 5a 1 (plastic surgery)
Cervical spine 1 1 (cervical fusion operation)
Olecranon bursa 1
Below waist
Foot ulcers 8b
Lower extremity 5 1 (arthroscopy of the knee)
Knee joint 3 1 (prosthetic joint surgery)
Hip joint 1 1 (prosthetic joint surgery)
Inguinal region 2
Abdominal wall 2 1 (gynaecological operation)
Urine 1
Prostatic gland 1 1 (prostatectomy)
Scrotum 1
Location unknown 2
aAll ﬁve were non-lactating women.
bFive patients with diabetes mellitus.
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Within this and other pulsotypes, isolates with
indistinguishable band patterns were found dur-
ing the 4-year study period. These patients had no
obvious connection, as they were treated in
different wards or at different hospitals. All
b-lactamase-positive isolates belonged to pulso-
type A. In contrast to PFGE, phenotypic analysis
with the Phene Plate System identiﬁed three
major clusters (Fig. 2) and two unclustered iso-
lates. Isolates belonging to pulsotype A were
distributed mainly in two of the three major
phenotypic clusters.
DISCUSSION
Previous reviews of S. lugdunensis infections have
also reported very few or no infections in children
[15,16,27], possibly because humans are colonised
during the later part of adolescence and hormonal
factors are involved. Most patients in the present
study were females (68%), but previous studies
[3,15,16] have reported an equal distribution
between men and women. Infections caused by
S. lugdunensis were located at various sites of the
body, but with a predominance (73% of non-
blood isolates) in the lower part of the body, which
is consistent with previous reports that most
S. lugdunensis infections involve sites below the
waist [16]. The prevalence of S. lugdunensis ingu-
inal carriage as part of the cutaneous ﬂora has
been found to be 22%, with the highest frequency
of carriage in women aged ‡ 65 years (51%) and
in men aged < 65 years (41%) [28]. In previous
reports, nine of 14 isolates of S. lugdunensis were
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Fig. 1. Genetic relationships and SmaI pulsed-ﬁeld gel electrophoresis (PFGE) patterns of 39 Staphylococcus lugdunensis
isolates obtained from 38 patients. The ﬁrst two numbers in the designations represent the year of isolation; B denotes
blood isolates; T denotes isolates from localised infections; PFGE groups are designated A–F; Si denotes an unclustered
isolate.
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obtained from abscesses in the pelvic region [27],
and in four patients suffering from endocarditis
caused by S. lugdunensis, three had an association
with inguinal, perineal or pelvic skin breaks,
caused by vasectomy, scrotal wound and renal
transplantation, respectively [2]. It has been sug-
gested that the preferred site for carriage of
S. lugdunensis may be the perineal and inguinal
regions [2,16,27,28], and the present study sup-
ports this theory. However, the number of infec-
tions localised in the inguinal or perineal region
was low.
Infections of the breast caused by S. lugdun-
ensis were found in 13% (5 ⁄ 38) of patients, and
these constituted most of the infections mani-
fested above the waist (5 ⁄ 7). Four of ﬁve
patients with breast abscesses had not received
previous surgery (all were non-lactating
women); the remaining patient had a wound
infection secondary to breast surgery. Breast
abscesses caused by S. lugdunensis in non-lacta-
ting women have been reported previously [17–
19,28], with S. lugdunensis being isolated in pure
culture in most cases. In four of the reported
cases, infection was secondary to breast surgery
[19,28], but in ﬁve cases the abscesses occurred
spontaneously [17–19]. It has been suggested
that the breast region is an additional site of
S. lugdunensis carriage [19,28]. Although it has
not been unequivocally demonstrated that
S. lugdunensis can adhere to the nipple or
areolar epithelium, it is reasonable to suppose
that it might colonise this region [19].
Only one of six patients with S. lugdunensis
bacteraemia had veriﬁed infective endocarditis.
S. lugdunensis endocarditis can be very aggressive
and, despite adequate antibiotic therapy, can
cause rapid destruction of heart valves [2–4].
Mortality is high if the valves are not replaced
[2,3]. S. lugdunensis affects native valvesmore often
than do other CoNS [2,3]. In contrast, S. lugdunensis
bacteraemia does not always cause a serious,
aggressive illness; thus, a retrospective analysis
of S. lugdunensis bacteraemia cases between 1990
and 2002 [29] revealed that only six of 20 cases
appeared to be clinically signiﬁcant, and of these
six patients, only one may have had infective
endocarditis and none had a severe illness.
In the present study, S. lugdunensiswas the only
pathogen isolated from 74% of non-bacteraemic
patients, compared to 81% in the study by
Vandenesch et al. [16] and 39% in the study by
Herchline and Ayers [15]. The only exceptions
were cultures from leg ulcers, where S. lugdunen-
sis was found frequently with other bacteria, and
probably represented colonisation. In general,
isolation of S. lugdunensis represents a signiﬁcant
ﬁnding more often than does the isolation of other
CoNS.
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Fig. 2. Phenotypic relationships, derived from Phene Plate
typing proﬁles, of 39 Staphylococcus lugdunensis isolates
obtained from 38 patients. The ﬁrst two numbers in the
designations represent the year of isolation; B denotes
blood isolates; T denotes isolates from localised infections;
the corresponding pulsed-ﬁeld gel electrophoresis (PFGE)
groups are designated A–F; Si denotes an isolate unclus-
tered by PFGE.
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In total, 15.4% of the S. lugdunensis isolates
were b-lactamase-positive, in agreement with
ﬁgures of c. 20% (http://www.srga.org) and
24% [24] reported previously. Measurement of
zone diameters in disk-diffusion tests appeared to
be a reliable method for detecting b-lactamase
production. The SRGA has recommended the use
of a cefoxitin disk (10 lg) instead of an oxacillin
disc (1 lg) for the detection of methicillin resist-
ance in staphylococci (http://www.srga.org). For
S. lugdunensis, the breakpoint for cefoxitin is
21 ⁄ 20 mm and that for oxacillin is 12 ⁄ 9 mm. In
the present study, all isolates were susceptible to
both cefoxitin and oxacillin, and the cefoxitin disk
was therefore found to be equivalent to an
oxacillin disk for identifying methicillin sensitiv-
ity in S. lugdunensis.
The oxacillin MIC breakpoints for CoNS recom-
mended by NCCLS are ‡ 0.5 mg ⁄L for resistance
and £ 0.25 mg ⁄L for susceptibility when using the
agar dilution method [30]. Hussain et al. [30]
found that many isolates of S. lugdunensis have
oxacillin MICs of 0.5–2 mg ⁄L (i.e., resistant
according to NCCLS guidelines); however, these
isolates were mecA-negative. Only one mecA-
positive isolate of S. lugdunensis has been repor-
ted, with an oxacillin MIC of > 256 mg ⁄L [22].
Therefore, detection of mecA itself, rather than
reliance upon phenotypic susceptibility tests (i.e.,
MIC), has been recommended [30]. In Sweden,
the Etest is used for determining MICs, and the
present study identiﬁed one isolate with an MIC
(1.5 mg ⁄L) that was above the SRGA breakpoint
for resistance, and one isolate with an MIC on the
breakpoint (1 mg ⁄L). Neither of these two isolates
carried mecA, but both were b-lactamase-positive,
and the higher MIC values were probably caused
by b-lactamase production, comparable to the
phenomenon of S. aureus isolates designated as
BORSA (borderline oxacillin-resistant S. aureus).
The S. lugdunensis isolates in the present study
were obtained from different patients in different
wards and hospitals during a 4-year period. Nev-
ertheless, there was a low degree of genomic
diversity among the isolates obtained frompatients
with manifest or clinically signiﬁcant infections,
with 56% belonging to one predominant pulso-
type. This may indicate that PFGE analysis of
S. lugdunensis isolates with SmaI digestion is not
appropriate or reliable for epidemiological
investigations, e.g., in an outbreak situation. This
interpretation may differ from that of van der
Mee-Marquet et al. [28]. Other restriction enzymes
have also been used, but nonewas superior to SmaI
[31]. One possibility is that the S. lugdunensis
genome is highly conserved, but a larger collection
of S. lugdunensis isolates obtained from various
parts of the worldwould need to be investigated to
conﬁrm this hypothesis. Another possibility might
be that speciﬁc clones of S. lugdunensis are more
likely to cause invasive infections. The Phene Plate
resultswere not congruentwith the PFGEpatterns,
although the isolates belonging to the predominant
pulsotype clustered in two of the three main
phenotypic groups. However, the Phene Plate
system may be suitable as a complementary labor-
atory technique in epidemiological investigations,
since these two methods reﬂect different charac-
teristics of the bacteria.
In conclusion, this study found that clinically
signiﬁcant infections caused by S. lugdunensis
were located in the breast or below the waist.
Isolates of S. lugdunensis were generally suscept-
ible to most of the antibiotics tested, and disk-
diffusion tests with penicillin G were a reliable
indicator of b-lactamase production. A low degree
of diversity between isolates was found, both
genotypically and phenotypically, with one pre-
dominant PFGE pulsotype following digestion of
chromosomal DNA with SmaI.
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